Evidence map›Paper›PMID 40994518›Full record

ArticleTherapeutic advances in infectious disease

A descriptive survey evaluating the implementation and outcomes of a training session highlighting concepts in antimicrobial management and harm reduction for hospital-based clinicians treating persons who use drugs.

Michael P Madaio, Wendy Y Craig, Amy Eckland, Nichole Moore, Rattanaporn Mahatanan, Colleen M Kershaw, William Bradford, Ellen Eaton, Alison B Rapoport, Monica K Sikka and 2 more

Abstract read
In one paragraph

Article in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Michael P MadaioMaineHealth Mid Coast Hospital, Division of Infectious Disease, 121 Medical Center Drive, Suite 2550, Brunswick, ME 04011-2652, USA.
Wendy Y CraigMaineHealth Institute for Research, Scarborough, ME, USA.
Amy EcklandTufts University School of Medicine, Boston, MA, USA.
Nichole MooreTufts University School of Medicine, Boston, MA, USA.
Rattanaporn MahatananDartmouth Hitchcock Medical Center, Section of Infectious Disease and International Health, Lebanon, NH, USA.
Colleen M KershawDartmouth Hitchcock Medical Center, Section of Infectious Disease and International Health, Lebanon, NH, USA.
William BradfordDivision of Infectious Disease, University of Alabama at Birmingham, Birmingham, AL, USA.
Ellen EatonDivision of Infectious Disease, University of Alabama at Birmingham, Birmingham, AL, USA.
Alison B RapoportCambridge Health Alliance, Medical Specialties, Somerville, MA, USA.
Monica K SikkaDivision of Infectious Diseases, Oregon Health & Science University, Portland, OR, USA.ORCID https://orcid.org/0000-0001-8192-8019
Hirofumi YoshidaDivision of Hospital Medicine, Oregon Health & Science University, Portland, OR, USA.
Kinna ThakararMaineHealth Maine Medical Center Portland, Division of Infectious Disease, 41 Donald B Dean Drive, Suite B, South Portland, ME 04106, USA.ORCID https://orcid.org/0000-0003-4689-0240

Funding

Understanding Factors Influencing COVID-19 Testing and Vaccination in Immigrant Low-income and Homeless Populations and Testing Targeted InterventionsU54GM115516 · NIGMS · MAINEHEALTH · PI Frances E. Carr · 2017 to 2026
$51.6M
NIGMS NIH HHS U54 GM115516
6 · The paper itself

Abstract

Background: People who use drugs (PWUD) are at increased risk for severe infections and face many barriers when completing conventional, typically parenteral antimicrobial treatments. Despite evidence supporting various antibiotic options, such as oral antibiotic therapy, there has been limited uptake of these strategies by many clinicians. Objectives: Create a training for hospital-based clinicians detailing harm reduction and various antimicrobial treatment options for the care of PWUD with severe infections. Examine current hospital-based clinician practices regarding the care of PWUD. Compare pre- and post-training clinician knowledge and comfort around various antibiotic treatment options, harm reduction, and substance use stigma. Design: The study design was a pre- and post-intervention descriptive survey. The intervention was the training session. Surveys were completed by participants before and after the training. Surveys were completed by participants before and after the training and asked about participants' practices and attitudes regarding PWUD and treatment options. Methods: The training was provided to hospital-based clinicians across eight different sites in four different states from November 2022 to November 2023. We examined knowledge, attitudes, and practices around treating injection drug use-associated infections, patients with substance use disorders, and comfort with antimicrobial treatment options using pre-and post-training surveys. We also used a modified version of a validated substance use stigma instrument to measure stigma pre- and post-training. For paired pre-post survey data, we used McNemar's test to compare Likert scale responses. Results: Of 167 study participants, 126 (75%) completed the pretraining survey, and 42 (25%) provided paired pre-post survey responses. Among the 126 pre-survey respondents, 64 (51%) were trainees, 75 (60%) frequently treated patients with injection drug use-associated infections, and 61 (50%) reported consistently applying harm reduction strategies to these patients in the hospital. Post-training, participants with paired data were significantly more likely to agree with applying harm reduction principles to the care of PWUD (pre, 23 (55%); post, 39 (95); Conclusion: Our study shows that an interactive training for hospital-based clinicians can significantly improve clinician knowledge and comfort with applying harm reduction strategies and with offering various antibiotic treatment options to PWUD with severe infections.

Indexed as

anti-bacterial agentseducationharm reductionsubstance-related disorders

Identifiers

PMID40994518
PMCPMC12454946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.